Market revenue in 2023 | USD 1,500.2 million |
Market revenue in 2030 | USD 2,083.9 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Devices |
Fastest growing segment | Drugs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Devices, Drugs |
Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 90.92% in 2023. Horizon Databook has segmented the Germany hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of a substantial number of providers offering new therapies and hearing devices is fueling market growth in the country. For instance, in May 2022, Acousia Therapeutics GmbH presented its new investigational treatment, ACOU085, for hearing loss at Inner Ear Therapeutics Summit in Boston.
Germany dominates the medical devices market in Europe. Despite the presence of some of the biggest medical devices companies globally, Germany mostly consists of Small and Medium-sized Enterprises (SMEs). It is open to implementing cutting-edge technology to help its highly regarded healthcare system.
In Germany, medical devices are governed by Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), also known as the Federal Institute for Drugs and Medical Devices. The Federal Ministry of Health operates BfArM. Germany's clinical assessments of medical devices are also supervised by BfArM.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into Germany hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account